Development of icterus gravis in a preterm infant with G71R UGT1A1 polymorphism

被引:1
|
作者
Kaga A. [1 ,2 ]
Ohkubo Y. [1 ,2 ]
Watanabe Y. [1 ,2 ]
Saito S. [1 ]
Matsuki T. [1 ,2 ]
Usuda H. [1 ,2 ]
Kanda S. [1 ]
Suzuki Y. [1 ]
Tanabu M. [1 ]
Kure S. [2 ]
机构
[1] Department of Pediatrics, Hachinohe City Hospital, Hachinohe, Aomori, 031-8555
[2] Department of Pediatrics, Tohoku University School of Medicine, Aoba-ku, Sendai, Miyagi, 980-8574, 1-1, Seiryo-machi
关键词
G71R; Gilbert's syndrome; Icterus gravis; Preterm infant; Uridine diphosphate-glucuronosyltransferase;
D O I
10.1186/1756-0500-6-51
中图分类号
学科分类号
摘要
Background: Uridine diphosphate-glucuronosyltransferase (UGT) gene family is involved in the detoxification of biomaterials and drugs in the liver. Among the UGT gene family members, only UGT1A1 is involved in bilirubin conjugation. As a result, deficient UGT1A1 activity causes jaundice. One disease that is characterized by reduced UGT1A1 activity is Gilbert's syndrome. Two prevalent UGT1A1 polymorphisms responsible for Gilbert's syndrome have been identified: G71R in exon 1 and A(TA)7TAA in the TATA box of the promoter region. Recently, the G71R polymorphism has been associated with breastfeeding jaundice and neonatal hyperbilirubinemia in term infants. However, its association with jaundice in very low birth weight infants (VLBWIs) has never been reported. Case presentation. The patient was a female born at 28 weeks, 4 days gestation with a birth weight of 1172 g. On day 21, intense yellowing of the skin and eyes was noted, and the patient's total bilirubin level was 23.7 mg/dL (her direct bilirubin level was 2.1 mg/dL). Therefore, an exchange transfusion was conducted. She had neither blood type incompatibility nor a family history of constitutional jaundice. Metabolic screens for amino and organic acids were negative. No elevation of any of the examined antibody titers was noted, and no evidence of an inflammatory reaction was observed. In addition, no hematological abnormalities were detected. The direct/indirect Coombs test, irregular antibody test and red blood cell antibody dissociation test were all negative, and her thyroid function was normal. We performed sequence analysis of the UGT1A1 gene after the patient's parents provided written informed consent. Exon 1 of the UGT1 gene on chromosome 2 was analyzed by direct sequencing. A heterozygous substitution from G to A (211G→A: G71R) in base 211 was noted. Conclusion: We speculated that this preterm infant with carrying the G71R polymorphism reduced UGT1A1 activity and developed severe jaundice that was likely triggered by factors such as breast feeding and medications. The polymorphism appears at some frequency among VLBWIs, which would necessitate adequate care of severe jaundice even after the acute phase. © 2013 Kaga et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [21] UGT1A1(TA)n promoter polymorphism -: A new case of a (TA)8 allele in Caucasians
    Ostanek, Barbara
    Furlan, Danijela
    Mavec, Tina
    Lukac-Bajalo, Jana
    BLOOD CELLS MOLECULES AND DISEASES, 2007, 38 (02) : 78 - 82
  • [22] A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease
    de Vries, Hilbert S.
    te Morsche, Rene H. M.
    Jenniskens, Kevin
    Peters, Wilbert H. M.
    de Jong, Dirk J.
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (05) : 597 - 602
  • [23] Wayward Effect of Polymorphism (TA)8 in the Promoter Region of UGT1A1 Gene in a Mexican Family
    Tintos-Hernandez, J. A.
    Perea, F. J.
    Ibarra, B.
    Figuera, L. E.
    WEST INDIAN MEDICAL JOURNAL, 2012, 61 (01) : 81 - 83
  • [24] UGT1A1 gene polymorphism as a potential factor inducing iron overload in the pathogenesis of type 1 hereditary hemochromatosis
    Romanowski, Tomasz
    Sikorska, Katarzyna
    Bielawski, Krzysztof Piotr
    HEPATOLOGY RESEARCH, 2009, 39 (05) : 469 - 478
  • [25] Genotyping UGT1A1(TA)n polymorphism rare variants by high resolution melting curve analysis
    Ostanek, Barbara
    Furlan, Danijela
    Bratanic, Borut
    CLINICA CHIMICA ACTA, 2011, 412 (5-6) : 489 - 490
  • [26] UGT1A1*28 polymorphism and acute lymphoblastic leukemia in children: a Danish case-control study
    Petersen, Jesper P.
    Overvad, Kim
    Hollegaard, Mads V.
    Ebbesen, Finn
    Henriksen, Tine B.
    Thorlacius-Ussing, Ole
    Hougaard, David M.
    Schroder, Henrik
    PEDIATRIC RESEARCH, 2014, 76 (05) : 459 - 463
  • [27] Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism
    Mobaraki, Sajedeh
    Nissen, Peter Henrik
    Donskov, Frede
    Wozniak, Agnieszka
    Van Herck, Yannick
    Coosemans, Lina
    van Nieuwenhuyse, Tine
    Lambrechts, Diether
    Bechter, Oliver
    Baldewijns, Marcella
    Roussel, Eduard
    Laenen, Annouschka
    Beuselinck, Benoit
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [28] UGT1A1 promoter polymorphism associated with serum bilirubin level in Saudi patients with sickle cell disease
    Hamad, Zainab
    Aljedai, Abdullah
    Halwani, Rabih
    AlSultan, Abdulrahman
    ANNALS OF SAUDI MEDICINE, 2013, 33 (04) : 372 - 376
  • [29] Roles of UGT1A1 Gly71Arg and TATA promoter polymorphisms in neonatal hyperbilirubinemia: A meta-analysis
    Wang, Jing
    Yin, Jiansong
    Xue, Mei
    Lyu, Jun
    Wan, Yu
    GENE, 2020, 736
  • [30] Early Complication in Sickle Cell Anemia Children due to A(TA)nTAA Polymorphism at the Promoter of UGT1A1 Gene
    Chaouch, Leila
    Talbi, Emna
    Moumni, Imen
    Ben Chaabene, Arij
    Kalai, Miniar
    Chaouachi, Dorra
    Mallouli, Fethi
    Ghanem, Abderraouf
    Abbes, Salem
    DISEASE MARKERS, 2013, 2013 : 67 - 72